Biogen Inc (BIIB)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BIIB? Forum Prognose Aktiensplit

Finanzdaten der Biogen Inc-Aktie (BIIB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.07% 2,279.40	2,534.70	2,645.50	2,431.00	2,465.80
Cost Of Revenue	26.53% 495.50	674.40	605.00	629.30	638.70
Gross Profit	4.11% 1,783.90	1,860.30	2,040.50	1,801.70	1,827.10
Operating Expenses	41.20% 1,839.90	1,303.00	1,296.50	1,490.50	1,376.10
Interest Income/Expense	0.15% 67.50	67.40	72.60	60.00	59.80
Benefits Costs and Expenses	18.10% 2,335.40	1,977.40	1,901.50	2,119.80	2,014.80
Costs And Expenses	18.10% 2,335.40	1,977.40	1,901.50	2,119.80	2,014.80
Operating Income/Loss	110.05% -56.00	557.30	744.00	311.20	451.00
Income/Loss From Continuing Operations Before Tax	110.05% -56.00	557.30	744.00	311.20	451.00
Income Tax Expense/Benefit, Deferred	34.24% 166.90	253.80	-31.30	-27.80	-52.60
Income Tax Expense/Benefit	107.82% -7.10	90.80	109.20	70.70	62.50
Income/Loss From Continuing Operations After Tax	110.48% -48.90	466.50	634.80	240.50	388.50
Net Income/Loss	110.48% -48.90	466.50	634.80	240.50	388.50
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.93% 0.10	146.60	146.50	146.10	145.70
Diluted Average Shares	99.80% 0.30	147.10	146.70	146.60	146.10
Basic Earnings Per Share	110.38% -0.33	3.18	4.33	1.65	2.67
Diluted Earnings Per Share	111.04% -0.35	3.17	4.33	1.64	2.66
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

PFE

$26.97

1.61%

NVO

$36.53

1.48%

GILD

$137.21

2.76%

AMGN

$347.80

0.61%

NVS

$146.03

1.46%

MRK

$114.18

0.02%